Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Appili Therapeutics Inc.
  6. News
  7. Summary
    APLI   CA03783R1073

APPILI THERAPEUTICS INC.

(APLI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Appili Therapeutics : Secures US$1 Million from FUJIFILM to Support Clinical Trials for Antivirals Against COVID-19

09/20/2021 | 08:28am EDT


© MT Newswires 2021
All news about APPILI THERAPEUTICS INC.
10/14APPILI THERAPEUTICS : Closes Public Offering of Near $7 Million
MT
10/07APPILI THERAPEUTICS : Prices Overnight Marketed Equity Offering -- Shares Down 13.5%
MT
10/07APPILI THERAPEUTICS : IIROC Trade Resumption - APLI
AQ
10/07APPILI THERAPEUTICS BRIEF : Prices Overnight Marketed Equity Offering
MT
10/07APPILI THERAPEUTICS : IIROC Trading Halt - APLI
AQ
10/07APPILI THERAPEUTICS : Announces Overnight Marketed Equity Offering
AQ
09/29APPILI THERAPEUTICS : AiPharma Enters into Strategic Alliance and Stock Swap Agreement wit..
PR
09/29APPILI THERAPEUTICS : AiPharma Enter Partnership, Equity Transaction
MT
09/29APPILI THERAPEUTICS : and AiPharma Announce Strategic Alliance and Equity Transaction
BU
09/29Appili Therapeutics Inc. and AiPharma Global Holdings LLC Announce Strategic Alliance a..
CI
More news
Financials
Sales 2022 29,9 M 24,2 M 24,2 M
Net income 2022 -20,5 M -16,5 M -16,5 M
Net Debt 2022 - - -
P/E ratio 2022 -2,19x
Yield 2022 -
Capitalization 49,9 M 40,3 M 40,2 M
Capi. / Sales 2022 1,67x
Capi. / Sales 2023 1,97x
Nbr of Employees 15
Free-Float 78,8%
Chart APPILI THERAPEUTICS INC.
Duration : Period :
Appili Therapeutics Inc. Technical Analysis Chart | APLI | CA03783R1073 | MarketScreener
Technical analysis trends APPILI THERAPEUTICS INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 0,70 CAD
Average target price 2,17 CAD
Spread / Average Target 210%
EPS Revisions
Managers and Directors
Armand L. Balboni Chief Executive Officer & Director
Kimberly Stephens Chief Financial Officer & Secretary
Ian C. Mortimer Chairman
Yoav Golan Chief Medical Officer
Theresa Matkovits Independent Director
Sector and Competitors
1st jan.Capi. (M$)
APPILI THERAPEUTICS INC.-42.62%40
GILEAD SCIENCES, INC.16.08%84 795
BIONTECH SE203.83%59 820
WUXI APPTEC CO., LTD.29.45%57 897
REGENERON PHARMACEUTICALS14.52%57 519
VERTEX PHARMACEUTICALS-23.09%47 156